Back to search
Hepatitis C Virus Infection, Response to Therapy of
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatitis C Virus Infection, Response to Therapy of trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hepatitis C Virus Infection, Response to Therapy of trials you may qualify forThis study is being done to compare two strategies to deliver HCV treatment to persons with hepatitis C virus (HCV) who also use drugs and are participating in…
The primary objective of this study is to evaluate the safety and efficacy of a Response Guided Therapy of boceprevir 800 mg dosed three times a day (TID) orall…
Hepatitis C virus (HCV) infection is among the most common of all chronic liver diseases. HCV predominantly affects liver cells and causes the liver to become i…